Through the filing of a Michigan GranuFlo lawsuit, those that have been injured by this dry acid concentrate may receive substantial compensation. Subsequently, a growing number of reports suggest that improper prescriptions of GranuFlo are responsible for serious and potentially life-threatening side effects. Those prescribed GranuFlo in conjunction with the standard practice of sodium bicarbonate may experience adverse cardiac events. Of particular concern, however, are reports that the developer of GranuFlo knew of these problems in 2011, yet failed to provide consumers with adequate warnings.
Free Michigan GranuFlo Lawsuit Evaluation: If you or a loved one has been injured by GranuFlo, you should contact our law firm immediately. You may be entitled to compensation by filing a Michigan GranuFlo lawsuit and we can help.
Michigan GranuFlo Lawsuit Overview
Administered during kidney dialysis, GranuFlo is indicated to remove harmful toxins from the blood and replace vital nutrients that were lost in the process. Furthermore, this concentrate was formulated for the use in a three-stream hemodialysis machine, which is calibrated for acid and bicarbonate concentrates. Therefore, GranuFlo, in conjunction with sodium bicarbonate, provides patients with a means of cleaning their blood while their kidneys are unable to.
Many clinicians may be unaware, however, that GranuFlo reintroduces patients to sodium bicarbonate. As such, standard procedure has practitioners prescribe sodium bicarbonate during dialysis to restore blood pH levels back to normal. The simultaneous administration of bicarbonate and GranuFlo may introduce a recipient to dangerous amounts of the compound. Therefore, the manufacturer is cautioning clinicians to be aware of the concentration of acetate or sodium diacetate (acetic acid plus acetate) contained in Granuflo Dry Acid Concentrate. Inappropriate prescription of these products can lead to a high serum bicarbonate level in patients undergoing hemodialysis.
Michigan GranuFlo lawyers are currently evaluating the link between this dialysis solution and the development of the following conditions:
- Low blood pressure
- Cardiopulmonary arrest
- Cardiac arrhythmia
- Sudden heart attack
- Hemodialysis cardiopulmonary arrest
- Cardiopulmonary death
Lawyer Michael Schmidt Elected to Plaintiffs’ Steering Committee For GranuFlo and NaturaLyte For GranuFlo and NaturaLyte Personal Injury Lawsuits Throughout The Country
Michael E. Schmidt, Managing Partner of Schmidt & Clark, LLP and The Schmidt Firm, LLP, was recently elected to the Plaintiffs’ Steering Committee in the Judicial Council Coordination Proceeding No. 4749 in Los Angeles Superior Court. The coordination proceeding applies to Granuflo and Naturalyte injury claims nationwide. This appointment establishes Mr. Schmidt in a leadership position in the litigation along with rest of the JCCP leadership panel.
A nationwide recall was issued for NaturaLyte and GranuFlo on March 29, 2012. Use of Fresenius Medical Care’s popular dialysis treatment products GranuFlo and NaturaLyte has been linked to a six-fold increased risk of cardiopulmonary arrest and sudden cardiac death.
Do I Have a Michigan GranuFlo Lawsuit?
The Product Liability & Defective Drug Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in GranuFlo lawsuits. We are handling individual litigation nationwide and currently accepting new GranuFlo injury and death lawsuits in Michigan.
Free Michigan GranuFlo Lawsuit Evaluation: Again, if you or a loved one has been injured by GranuFlo, you should contact our law firm immediately. You may be entitled to compensation by filing a Michigan GranuFlo lawsuit and we can help.